E. Coli Testing Market Size by Application, Type, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2030
Overview
E. coli Testing Market is expected to reach US$ 364.55 million at a CAGR of 6.1% during the forecast period 2030.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology:-Request Free Sample Report
Escherichia coli (E. coli) are rod-shaped gram-negative bacteria that are usually found in the environment, foods, and intestines of warm-blooded animals. Most of the E.coli strains are usually harmless to humans, but some strains identified to cause serious diseases like gastrointestinal tract infections, cholangitis, cholecystitis, bacteraemia, neonatal meningitis and pneumonia, urinary tract infection (UTI), which are mostly spread via contaminated food or water.
The growing public awareness, increase in product launches, and numerous FDA approvals for new instruments are the primary drivers for the market growth in this region. Lack of cleanliness and the general negligence of maintaining hygiene has been chiefly responsible for driving the global E. coli testing market. Rising worries about anti-microbial resistance acquired by those affected are also driving the global E. coli testing market, by prompting extensive research on the bacterium, especially with regards to its resistance power. Increasing government support for E. coli testing, increasing occurrence and high illness of E. coli infection globally is expected to drive the future market growth of E. coli testing.
However, high costs of E. coli treatments are especially obstructing the E. coli testing market, mainly by depressing those having less non-refundable income. Many underdeveloped and distant regions show a lack of healthcare experts, consequently restraining the market’s growth. But, extensive research and innovations are being carried out by several players, and this is expected to reduce the restraints up to a certain extent.
Region-wise, the North Americas accounted for almost XX% of the market share in 2023 and is expected to grow at a CAGR of over XX% during the forecast period. Upcoming technological advancement along with rising use of polymerase chain reaction (PCR) tests for environment water testing expected to open up new growth opportunities during the forecast period.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global E. Coli Testing market dynamics, structure by identifying and analysing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global gram E. Coli Testing market.
E. Coli Testing Market Scope: Inquire before buying
| E. Coli Testing Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | US $ 240.85 Mn. |
| Forecast Period 2024 to 2030 CAGR: | 6.1% | Market Size in 2030: | US $ 364.55 Mn. |
| Segments Covered: | by Application | Hospitals Diagnostic Laboratories Water Treatment Agencies Others |
|
| by Type | Clinical Environmental |
||
E. coli Testing Market by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
E. Coli Testing Market Key Players
1. Abbott Laboratories
2. Beckman Coulter
3. Wako
4. Becton
5. Dickinson and Company
6. Affymetrix
7. bioMrieux
8. Bio-Rad Laboratories
9. Thermo Fisher Scientific
10. Siemens
11. Hoffmann-La Roche
12. Cepheid
13. GenBio
14. Olympus
15. Novartis
16. Johnson & Johnson
17. Pro-Lab Diagnostics, Inc.
18. IDEXX Laboratories, Inc.
19. Meridian Bioscience, Inc.
Frequently Asked Questions:
1. Which region has the largest share in Global E. coli Testing Market?
Ans: North America region held the highest share in 2023.
2. What is the growth rate of Global E. coli Testing Market?
Ans: The Global E. coli Testing Market is growing at a CAGR of 6.1% during forecasting period 2024-2030.
3. What is scope of the Global E. coli Testing market report?
Ans: Global E. coli Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global E. coli Testing market?
Ans: The important key players in the Global E. coli Testing Market are – Abbott Laboratories, Beckman Coulter, Wako, Becton, Dickinson and Company, Affymetrix, bioMrieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Siemens, Hoffmann-La Roche, Cepheid, GenBio, Olympus, Novartis, Johnson & Johnson, Pro-Lab Diagnostics, Inc., IDEXX Laboratories, Inc., Meridian Bioscience, Inc., CPI International, Biomerieux Inc., Hologic, Inc, and
5. What is the study period of this market?
Ans: The Global E. coli Testing Market is studied from 2023 to 2030